These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 1679381)

  • 1. The murine epsilon receptor modulating protein: a novel serine protease which modulates CD23 binding of IgE.
    Matsushita S; Katz DH
    Cell Immunol; 1991 Oct; 137(1):252-9. PubMed ID: 1679381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a T cell membrane protein possibly involved in IL-4-induced B cell immunoglobulin class switching to IgE.
    Matsushita S; Katz DH
    Cell Immunol; 1994 Feb; 153(2):378-91. PubMed ID: 8118870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low affinity IgE receptors: regulation and functional roles in cell activation.
    Yodoi J; Hosoda M; Maeda Y; Sato S; Takami M; Kawabe T
    Ciba Found Symp; 1989; 147():133-48; discussion 148-52. PubMed ID: 2533550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A monoclonal anti-IgE antibody against an epitope (amino acids 367-376) in the CH3 domain inhibits IgE binding to the low affinity IgE receptor (CD23).
    Chrétien I; Helm BA; Marsh PJ; Padlan EA; Wijdenes J; Banchereau J
    J Immunol; 1988 Nov; 141(9):3128-34. PubMed ID: 2459242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biphasic effect of kallikrein on IgE and IgG1 syntheses by LPS/IL-4-stimulated B cells.
    Matsushita S; Katz DH
    Cell Immunol; 1993 Jan; 146(1):210-4. PubMed ID: 8425228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IFN-gamma and prostaglandin E2 inhibit IL-4-induced expression of Fc epsilon R2/CD23 on B lymphocytes through different mechanisms without altering binding of IL-4 to its receptor.
    Galizzi JP; Cabrillat H; Rousset F; Ménétrier C; de Vries JE; Banchereau J
    J Immunol; 1988 Sep; 141(6):1982-8. PubMed ID: 2844892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allergen-directed expression of Fc receptors for IgE (CD23) on human T lymphocytes is modulated by interleukin 4 and interferon-gamma.
    Prinz JC; Baur X; Mazur G; Rieber EP
    Eur J Immunol; 1990 Jun; 20(6):1259-64. PubMed ID: 2142456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant soluble Fc epsilon receptor II (Fc epsilon RII/CD23) has IgE binding activity but no B cell growth promoting activity.
    Uchibayashi N; Kikutani H; Barsumian EL; Hauptmann R; Schneider FJ; Schwendenwein R; Sommergruber W; Spevak W; Maurer-Fogy I; Suemura M
    J Immunol; 1989 Jun; 142(11):3901-8. PubMed ID: 2523938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of formation of human IgE-binding factors (soluble CD23): III. Evidence for a receptor (Fc epsilon RII)-associated proteolytic activity.
    Letellier M; Nakajima T; Pulido-Cejudo G; Hofstetter H; Delespesse G
    J Exp Med; 1990 Sep; 172(3):693-700. PubMed ID: 2143772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding site for IgE of the human lymphocyte low-affinity Fc epsilon receptor (Fc epsilon RII/CD23) is confined to the domain homologous with animal lectins.
    Bettler B; Maier R; Rüegg D; Hofstetter H
    Proc Natl Acad Sci U S A; 1989 Sep; 86(18):7118-22. PubMed ID: 2476812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of Fc epsilon RII/CD23 on phytohemagglutinin-activated human peripheral blood T lymphocytes. I. Enhancement by IL-2 and IL-4.
    Kawabe T; Maekawa N; Maeda Y; Hosoda M; Yodoi J
    J Immunol; 1991 Jul; 147(2):548-53. PubMed ID: 1830067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoglobulin E-binding site in Fc epsilon receptor (Fc epsilon RII/CD23) identified by homolog-scanning mutagenesis.
    Bettler B; Texido G; Raggini S; Rüegg D; Hofstetter H
    J Biol Chem; 1992 Jan; 267(1):185-91. PubMed ID: 1530929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding the low affinity Fc epsilon R on B cells suppresses ongoing human IgE synthesis.
    Sherr E; Macy E; Kimata H; Gilly M; Saxon A
    J Immunol; 1989 Jan; 142(2):481-9. PubMed ID: 2521348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidermal Langerhans cells from normal human skin bind monomeric IgE via Fc epsilon RI.
    Wang B; Rieger A; Kilgus O; Ochiai K; Maurer D; Födinger D; Kinet JP; Stingl G
    J Exp Med; 1992 May; 175(5):1353-65. PubMed ID: 1533243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fc epsilon RII/CD23: the low affinity receptor for IgE.
    Conrad DH
    Annu Rev Immunol; 1990; 8():623-45. PubMed ID: 2140512
    [No Abstract]   [Full Text] [Related]  

  • 16. Differential regulation of the low affinity Fc receptor for IgE (Fc epsilon R2/CD23) and the IL-2 receptor (Tac/p55) on eosinophilic leukemia cell line (EoL-1 and EoL-3).
    Hosoda M; Makino S; Kawabe T; Maeda Y; Satoh S; Takami M; Mayumi M; Arai K; Saitoh H; Yodoi J
    J Immunol; 1989 Jul; 143(1):147-52. PubMed ID: 2525145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Purification of murine suppressive factor of allergy into distinct CD23-modulating and IgE-suppressive proteins.
    Matsushita S; Marcelletti JF; Katz LR; Katz DH
    Proc Natl Acad Sci U S A; 1991 Jun; 88(11):4718-22. PubMed ID: 1828884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thromboxane release by lymphokine-differentiated U937 human monocytic cells: response to platelet-activating factor (PAF) and chemotactic peptide (FMLP) but not to low affinity IGE-receptor (Fc epsilon RII/CD23) occupation.
    Storch J; Edwards RJ; MacDermot J
    J Leukoc Biol; 1990 Sep; 48(3):266-73. PubMed ID: 2144015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An update on human CD23 (Fc epsilon RII). Fc epsilon RII and IgE-BFs (soluble CD23) play an essential role in the regulation of human IgE synthesis.
    Delespesse G; Sarfati M
    Clin Exp Allergy; 1991 Jan; 21 Suppl 1():153-61. PubMed ID: 1827751
    [No Abstract]   [Full Text] [Related]  

  • 20. The low-affinity receptor for IgE (CD23) on B lymphocytes is spatially associated with HLA-DR antigens.
    Bonnefoy JY; Guillot O; Spits H; Blanchard D; Ishizaka K; Banchereau J
    J Exp Med; 1988 Jan; 167(1):57-72. PubMed ID: 2961843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.